# Clonal Hematopoiesis of Immunological Significance

> **NCT05969821** · — · NOT_YET_RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 5000 (estimated)

## Conditions studied

- Immune System Diseases
- Autoimmune Diseases
- Inflammation
- Autoinflammatory Diseases
- Vexas Syndrome
- Hematopoiesis Clonal
- Clonal Hematopoiesis of Indeterminate Potential
- Hematologic Diseases
- Myelodysplastic-Myeloproliferative Diseases
- Leukemia Myelomonocytic Chronic
- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- Lymphoproliferative Disorders
- Lymphoma
- Leukemia
- Monoclonal Gammopathy of Undetermined Significance

## Interventions

- **OTHER:** observational cohort study

## Key facts

- **NCT ID:** NCT05969821
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2036-04
- **Final completion:** 2045-09
- **Target enrollment:** 5000 (ESTIMATED)
- **Last updated:** 2026-03-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05969821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05969821, "Clonal Hematopoiesis of Immunological Significance". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05969821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*